Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · IEX Real-Time Price · USD
1.360
-0.030 (-2.16%)
At close: Apr 25, 2024, 4:00 PM
1.320
-0.040 (-2.94%)
After-hours: Apr 25, 2024, 4:07 PM EDT
CNTB Market Cap
CNTB has a market cap or net worth of $74.94 million as of April 26, 2024. Its market cap has increased by 27.23% in one year.
Market Cap
74.94M
Enterprise Value
58.63M
1-Year Change
27.23%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since the IPO on March 19, 2021, CNTB's market cap has decreased from $948.88M to $74.94M, a decrease of -92.10%. That is a compound annual growth rate of -55.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 74.90M | -0.79% |
Apr 24, 2024 | 75.50M | -1.44% |
Apr 23, 2024 | 76.60M | 2.96% |
Apr 22, 2024 | 74.40M | -12.37% |
Apr 19, 2024 | 84.90M | 1.31% |
Apr 18, 2024 | 83.80M | -1.87% |
Apr 17, 2024 | 85.40M | -10.39% |
Apr 16, 2024 | 95.30M | 3.70% |
Apr 15, 2024 | 91.90M | -2.96% |
Apr 12, 2024 | 94.70M | -10.41% |
Apr 11, 2024 | 105.70M | 3.22% |
Apr 10, 2024 | 102.40M | -0.49% |
Apr 9, 2024 | 102.90M | 3.83% |
Apr 8, 2024 | 99.10M | -15.87% |
Apr 5, 2024 | 117.80M | 18.87% |
Apr 4, 2024 | 99.10M | -15.44% |
Apr 3, 2024 | 117.20M | 2.36% |
Apr 2, 2024 | 114.50M | -5.45% |
Apr 1, 2024 | 121.10M | 26.41% |
Mar 28, 2024 | 95.80M | 8.13% |
Mar 27, 2024 | 88.60M | 21.04% |
Mar 26, 2024 | 73.20M | 4.72% |
Mar 25, 2024 | 69.90M | -0.85% |
Mar 22, 2024 | 70.50M | 3.22% |
Mar 21, 2024 | 68.30M | -0.73% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
LAVA Therapeutics | 78.34M |
Athira Pharma | 78.19M |
Cognition Therapeutics | 78.00M |
Tiziana Life Sciences | 77.96M |
Spero Therapeutics | 77.34M |
Tempest Therapeutics | 75.90M |
Passage Bio | 75.78M |
Corvus Pharmaceuticals | 75.03M |